Magenta Therapeutics

The 2023 Biotech Graveyard
Fierce Biotech
Tue, 10/31/23 - 11:34 am
biotech
Rubius Therapeutics
Nabriva Therapeutics
Calithera Biosciences
Goldfinch Bio
Antios Therapeutics
Magenta Therapeutics
Coda Biotherapeutics
Aristea Therapeutics
Magenta agrees to reverse merger with Dianthus after setbacks
BioPharma Dive
Wed, 05/3/23 - 10:48 pm
Magenta Therapeutics
M&A
Dianthus Therapeutics
autoimmune disease
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Magenta's C-suite heads out the door with 85% of staff as closing process gets underway
Fierce Biotech
Thu, 02/9/23 - 10:50 am
Magenta Therapeutics
layoffs
executives
Days after halting leukemia drug, Magenta moves to close its doors
Fierce Biotech
Thu, 02/2/23 - 11:11 pm
Magenta Therapeutics
leukemia
Patient death spurs trial halt for Magenta Therapeutics
Endpoints
Thu, 01/26/23 - 10:38 am
Magenta Therapeutics
MGTA-117
clinical trials
patient deaths
AML
myelodysplastic syndrome
Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%
Pulse 2.0
Wed, 12/21/22 - 11:27 am
Magenta Therapeutics
clinical trials
MGTA-117
AML
myelodysplastic syndrome
Big Pharma Is Going Holiday Shopping. Who's Next?
Motley Fool
Wed, 11/10/21 - 10:13 am
Big Pharma
M&A
ChemoCentryx
Epizyme
Magenta Therapeutics
Magenta Down After FDA Places Clinical Hold on IND for AML/MDS Drug
BioSpace
Wed, 07/21/21 - 08:41 pm
Magenta Therapeutics
AML
MDS
FDA
clinical hold
MGTA-117
Magenta's R&D head hits the exit just weeks after reading out mid-stage data for lead therapy, eyeing clinic for another
Endpoints
Thu, 05/27/21 - 11:05 am
Magenta Therapeutics
stem cells
stem cell transplant
clinical trials
Magenta, Beam partner to explore use of antibody-based conditioning drug for gene therapies
MedCity News
Mon, 06/15/20 - 10:25 am
Magenta Therapeutics
Beam Therapeutics
MGTA-117
gene therapy
sickle cell disease
beta thalassemia
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
2 Small-Cap Biotechs That Soared Last Week
Motley Fool
Tue, 11/26/19 - 09:42 am
Magenta Therapeutics
Molecular Templates
gene therapy
CAR-T
cancer
Magenta Therapeutics presents updated Phase 2 clinical data on MGTA-456 cell therapy
Pharmaceutical Business Review
Fri, 05/10/19 - 10:32 am
Magenta Therapeutics
cell therapy
clinical trials
MGTA-456
inherited metabolic disorders
metabolic disorders
Magenta stem cell transplant drug seems to work, but is it safe?
Fierce Biotech
Thu, 11/1/18 - 12:20 pm
Magenta Therapeutics
MGTA-456
clinical trials
stem cells
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours
Xconomy
Thu, 06/21/18 - 12:04 pm
biotech
IPOs
Eidos Therapeutics
Avrobio
XERIS
Aptinyx
Kezar Life Sciences
Magenta Therapeutics
Three Biotechs Announced IPOs Friday
BioSpace
Sun, 06/10/18 - 07:09 pm
IPOs
Autolus
Magenta Therapeutics
MeiraGTx
Magenta Therapeutics Launches $100 Million IPO
CP Wire
Fri, 06/8/18 - 11:08 am
Magenta Therapeutics
IPOs
Magenta Therapeutics Launches $100 Million IPO
Fri, 06/8/18 - 11:07 am
Magenta Therapeutics
Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it
Endpoints
Wed, 05/3/17 - 10:52 am
Magenta Therapeutics
Novartis
stem cells
HSC835